Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetazolamide on Exercise and Cognition in Hypoxia
NCT03525561Phase 1Completed
- Sponsor
- U.S. Army Research Institute of Environmental Medicine
- Start
- Oct 2018
- Primary completion
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of acetazolamide in acute mountain sickness (AMS), sponsored by U.S. Army Research Institute of Environmental Medicine. Started Oct 2018; status: completed.
02
Drugs
acetazolamide
03
Conditions
acute mountain sickness (AMS)
Beyond the preview
Go deeper on NCT03525561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03525561.